Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY:ATNM)
1.600
+0.220
(+15.94%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 22, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 828,819 |
| Open | 1.330 |
| Bid (Size) | 1.550 (100) |
| Ask (Size) | 1.590 (200) |
| Prev. Close | 1.380 |
| Today's Range | 1.330 - 1.660 |
| 52wk Range | 0.7351 - 1.740 |
| Shares Outstanding | 21,331,314 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read MoreFrequently Asked Questions
Is Actinium Pharmaceuticals, Inc. (Delaware) Common Stock publicly traded?
Yes, Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is publicly traded.
What exchange does Actinium Pharmaceuticals, Inc. (Delaware) Common Stock trade on?
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The ticker symbol for Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is ATNM on the New York Stock Exchange
What is the current price of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The current price of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is 1.600
When was Actinium Pharmaceuticals, Inc. (Delaware) Common Stock last traded?
The last trade of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock was at 10/22/26 08:00 PM ET
What is the market capitalization of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock?
The market capitalization of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock is 34.13M
How many shares of Actinium Pharmaceuticals, Inc. (Delaware) Common Stock are outstanding?
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock has 34M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.